DIRS.INFO The most relevant business & tech news

Wegovy, the blockbuster weight loss treatment from Novo Nordisk , tops the list of drugs that could soon become part of the second round of price negotiations between manufacturers and Medicare. The Biden administration last month announced new negotiated prices for the first 10 Medicare Part D drugs selected for the talks. He also pushed back on Medicare price negotiations when asked about the potential selection of Wegovy and Ozempic, calling the talks "price-setting" that will have negative consequences for drug innovation. Medicare Part D doesn't cover weight loss treatments unless they are approved and prescribed for another health condition. We'll be following the next round of Medicare drug price negotiations closely, so stay tuned for our coverage.

Persons: Wegovy, Hollie Adams, Biden, it's, Novo, Lars Fruergaard Jørgensen, Lars Jorgensen, Ozempic, Piroschka Van De Wouw, Jørgensen, Semaglutide, We'll, Annika, annikakim.constantino Organizations: Novo Nordisk, Reuters, Specialty Pharmacy, Centers, Medicare, Medicaid Services, Health, Education, Labor, Capitol, CMS, Wall Street, GSK, Astellas Pharma, Epic Systems Locations: London, Britain, Novo, Washington , U.S

☆ China says relations with Japan at 'critical stage'
▼ + stars: | 2024-07-27 | by ( ) www.cnbc.com time to read: +2 min

Relations between China and Japan are at a critical stage, Chinese Foreign Minister Wang Yi told his Japanese counterpart on Friday as the pair discussed thorny issues including Japanese nationals detained in China, food import bans and semiconductor curbs. "China-Japan relations are currently at a critical point: advance or be left behind," Wang told Kamikawa, according to a readout of the talks issued by the Chinese foreign ministry. It is hoped that the Japanese side will establish an objective and correct perception of China and pursue a positive and rational policy towards China." In their first one-to-one talks in eight months, Kamikawa strongly urged the lifting of import restrictions Beijing imposed on Japan food products in the wake of the Fukushima water release. She also called for the early release of Japan detainees in China.

Persons: Wang Yi, Wang, Japan's Yoko Kamikawa, Kamikawa Organizations: Southeast, ASEAN, Saturday's East Asia Summit, ASEAN Regional Forum, Japan, Astellas Pharma Locations: China, Japan, Laos, Saturday's, Beijing, Tokyo

☆ This overlooked corner of women's health could be a $350 billion market opportunity
▼ + stars: | 2024-03-15 | by ( Michelle Fox | ) www.cnbc.com time to read: +5 min

The management consultant estimates the global market potential to treat symptoms ranges from $120 billion to as much as $350 billion globally. "That would apply to women's health in general, and then specifically and acutely to menopause in particular." From 2002 to 2009, hormone therapy claims were reduced by more than 70%, a 2012 study showed. The clinical-stage biopharmaceutical company, which focuses on women's health, has an intravaginal ring hormone therapy that is set to progress to a single Phase 3 study. Last May, the Food and Drug Administration approved Tokyo-based Astellas Pharma's Veozah, also known as fezolinetant, to treat hot flashes.

Persons: Drew Barrymore, Naomi Watts, Anna Pione, Stephanie Faubion, Faubion, Karen Adams, Jefferies, Kaumil Gajrawala, Bayer, Progyny, Sasha Kelemen Organizations: McKinsey, Health, Mayo Clinic Center, Women's Health, Stanford University, Pfizer, Dare, Food and Drug Administration, Vistagen Therapeutics, Gennev, Midi Health, Leerink Partners Locations: U.S, Tokyo

☆ Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
▼ + stars: | 2024-03-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +13 min

Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. That $43 billion Seagen acquisition doubled Pfizer's oncology drug pipeline to 60 different experimental programs. Some analysts noted that it might take a few years for some of Pfizer's cancer drugs in mid-stage development to show pivotal clinical trial data and become less risky. Revenue from the blockbuster breast cancer drug Ibrance and prostate cancer treatment Xtandi, which Pfizer shares with Astellas Pharma, has declined over the past year. They are among the most expensive prescription drugs in the U.S. Before the Seagen deal, 94% of Pfizer's cancer products were small-molecule drugs.

Persons: Wall, Seagen, Chris Boshoff, Boshoff, David Ryder, Trung Huynh, Joe Biden's, Chris Schott, Suneet Varma, RemeGe, Merck, Padcev, Guggenheim, Pfizer's, Pfizer hasn't, Dr, Mikael Dolsten, Irfan Khan Organizations: Nurphoto, Getty, Pfizer, Astellas Pharma, Guggenheim, Bloomberg, UBS, Medicare, Drug Administration, FDA, ADC, JPMorgan, Drugs, CNBC, CVS Pharmacy, Los Angeles Times Locations: Covid, Bothell , Washington, U.S, biologics, China, Eagle Rock , California

☆ Japan Business Leaders Return to China Seeking to Bolster Cooperation
▼ + stars: | 2024-01-24 | by ( Jan. | At P.M. | ) www.usnews.com time to read: +3 min

Japanese economic delegations had visited China every year since 1975, but those visits lapsed during the COVID-19 era when China largely shuttered its borders due to its stringent pandemic policies. During their visit this week, the Japanese business delegates, which included Masakazu Tokura, chairman of the powerful Keidanren, as the Japan Business Federation is known, are due to meet with Chinese Premier Li Qiang on Thursday. Japan is heavily reliant on China, where Japanese companies have for years invested in building manufacturing supply chains and forged relationships with local partners. China last year arrested a Japanese executive, an employee of the drugmaker Astellas Pharma, on suspicion of espionage. The move has had a chilling effect on business, Japanese officials say.

Persons: Masakazu Tokura, Premier Li Qiang, Fumio, Xi Jinping, Wang Yi, Gamble, Ryan Woo, Miyoung Kim, David Dolan, Michael Perry Organizations: Japan Business, Premier, Pharma, Procter, SK, Nidec Corp, Toyota, Nissan Locations: BEIJING, China, Japan, United States, Kishida, Greater China, Beijing, Singapore, Tokyo

Japan's Prime Minister Fumio Kishida and Chinese President Xi Jinping pose for a family photo during Asia-Pacific Economic Cooperation (APEC) CEO Summit in San Francisco, California, U.S. November 16, 2023. They also pledged to hold high-level dialogue on economic issues and welcomed the launch of a framework to discuss export controls as they met on the sidelines of an Asia Pacific Economic Cooperation summit. In a joint statement in 2008, Japan and China agreed to pursue a "mutually beneficial relationship based on common strategic interests" designed to ensure frequent leadership exchanges on issues such as security and economic cooperation. On the sidelines of the APEC summit, Kishida has also met South Korean President Yoon Suk Yeol for their seventh meeting this year. Leaders from the 21-member Asia-Pacific Economic Cooperation forum are in San Francisco for its 30th summit from Nov. 15-17.

Persons: Fumio Kishida, Xi Jinping, Carlos Barria, Xi, Kishida, Joe Biden, Biden, Washington, Rumi Aoyama, Aoyama, Yoon Suk, Yoon, Mariko Katsumura, John Geddie, Kaori Kaneko, Sakura Murakami, Ethan Wang, Stephen Coates, Raju Gopalakrishnan Organizations: Japan's, Economic Cooperation, REUTERS, Asia, Astellas Pharma, ., Waseda Institute of Contemporary Chinese, APEC, South, Thomson Locations: Asia, San Francisco , California, U.S, China, San Francisco, Japan, Taiwan, Beijing, United States, Tokyo

China detained the executive, named in several media reports as Hiroshi Nishiyama, on suspicion of espionage in March, and he was formally arrested last month. Japan's then foreign minister protested the executive's detention with his Chinese counterpart on a visit to Beijing in April. China's foreign ministry did not immediately respond to a request for comment. Half the respondents in a recent survey of Japanese companies doing business in China said they would cut investments this year. It's a very difficult point in time to be navigating that as a decision maker, in business or politics," he said.

Persons: Fumio Kishida, Xi Jinping, Rahm Emanuel, Hiroshi Nishiyama, Japan's, Xi, Masashi Mizobuchi, Nishiyama, Takeshi Niinami, Niinami, Stefan Angrick, Yukiko Toyoda, Kiyoshi Takenaka, John Geddie, Sakura Murakami, Francis Tang, Laurie Chen, Antoni Slodkowski, Andrew Silver, Lincoln Organizations: Economic Cooperation, Kyodo, drugmaker Astellas Pharma, APEC, Reuters, Japanese Chamber of Commerce, Japan Association of Corporate, Suntory, Moody's Analytics, Thomson Locations: Asia, Bangkok, Thailand, TOKYO, BEIJING, China, San Francisco, Tokyo, U.S, Japan, Beijing, officialdom, Shanghai

☆ Apple iPhone maker Foxconn being investigated in China as founder runs for Taiwan presidency
▼ + stars: | 2023-10-23 | by ( Laura He | ) edition.cnn.com time to read: +6 min

Hong Kong CNN —Taiwan’s Foxconn, one of Apple’s largest suppliers, is being investigated by authorities in China, according to state media. Foxconn, also known as Hon Hai Precision Industry, has iPhone factories in Guangdong and Henan, including the world’s largest in the city of Zhengzhou. The company’s listed unit in Shanghai, Foxconn Industrial Internet, plummeted by its daily limit of 10% on Monday. Terry Gou, Foxconn founder, announces bid for Taiwan presidency during a press event in Taipei on August 28. The crackdown came despite repeated calls from Chinese leaders to welcome more foreign investment to boost the country’s slowing economy.

Persons: Taiwan’s, Terry Gou, won’t, Foxconn, “, ”, Brock Silvers, Gou, Hai, ” Gou, Ann Wang, Lai Ching, — Hou Yu, Ko Wen, Zhang Wensheng, ” Zhang, Silvers Organizations: Hong Kong CNN, Global Times, CNN, Hai Precision Industry, Foxconn Technology, WPP, drugmaker Astellas Pharma, Kaiyuan, “, Apple, Communist, Taiwan, Democratic People’s Party, ih, Kuomintang, Taiwan People’s Party, Beijing, China’s Xiamen University, Financial Times, Shanghai, Economic Observer Locations: China, Hong Kong, Beijing, Guangdong, Jiangsu, Henan, Hubei, Zhengzhou, Shanghai, Taipei, Taiwan

☆ WPP fires executive detained in China on suspicion of bribery
▼ + stars: | 2023-10-23 | by ( Michelle Toh | ) edition.cnn.com time to read: +3 min

Hong Kong CNN —Advertising giant WPP says it has fired an executive detained in China on suspicion of bribery. Last week, news emerged that the Chinese police had raided the Shanghai office of advertising agency GroupM, owned by WPP. WPP said Tuesday it had fired an executive detained in China on suspicion of bribery. The police didn’t name the company, but the Financial Times and Chinese state media linked it to GroupM. The announcement came a month after police questioned employees at the Shanghai office of top consultancy Bain.

Persons: ”, Terry Gou, wouldn’t, Mintz Organizations: Hong Kong CNN —, WPP, CNN, Reuters, Shanghai, Financial Times, drugmaker Astellas Pharma, China, Mintz Group, Bain Locations: China, Hong Kong, Shanghai, Beijing

☆ Bladder cancer studies suggest new ways to treat the disease and improve survival
▼ + stars: | 2023-10-22 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +9 min

This is one of several new studies exploring ways to improve how bladder cancer is treated. “Ever since I was in med school, a metastatic bladder cancer treatment was gemcitabine and platinum. Urothelial cancer is a type of bladder cancer that begins in the urothelial cells, which line the inside of the bladder. The drug became the first therapy targeting a genetic alteration to be approved by the FDA to treat patients with the most common type of bladder cancer, metastatic urothelial cancer. “These results support nivolumab plus cisplatin-based chemo as a new standard approach for the treatment of metastatic urothelial cancer.”

Persons: vedotin, hadn’t, ”, Thomas Powles, ” Powles, we’ve, —, Powles, Toni Choueiri, Dana, “, enfortumab, ” Choueiri, drugmaker Janssen, Dr, Sanjay Gupta, nivolumab, Matthew Galsky Organizations: CNN, Society for Medical Oncology, University of London, Barts Cancer, US, Inc, Astellas Pharma, Merck, Co, Food and Drug Administration, FDA, EMA, Lank, Genitourinary Oncology, Farber Cancer Institute, ESMO, New England, of Medicine, University of Texas, Anderson Cancer Center, US Food and Drug Administration, National Library of Medicine, CNN Health, Bristol Myers Squibb, Ono Pharmaceutical Company, Cancer, The Tisch Cancer Institute Locations: Madrid, United Kingdom, United States, Europe, Mount Sinai

Tokyo CNN —China has formally arrested a Japanese man who was detained in March, according to officials from Japan’s Ministry of Foreign Affairs (MOFA) and the Japanese Embassy in Beijing. The arrest of the Japanese national, who was reportedly an employee of a Tokyo-based pharmaceutical firm, could further rattle foreign businesses in China, which have reported feeling more unsettled this year amid a crackdown on international consulting firms on national security grounds. According to Japanese public broadcaster NHK, the man was an employee of drugmaker Astellas Pharma and was detained in March by Chinese security authorities in Beijing on suspicion of violating the country’s criminal law and anti-espionage law. In May, state security authorities said they had raided several offices of Capvision, an advisory network. The issue has been cited as headache for foreign businesses, some of which were already having trouble convincing workers to relocate to China.

Persons: Hirokazu Matsuno, Japan’s MOFA, Mao Ning, “, ”, Weeks, Bain, — CNN’s Michelle Toh, Sophie Jeong, Mengchen Zhang Organizations: Tokyo CNN, Japan’s Ministry of Foreign Affairs, Embassy, NHK, drugmaker, Pharma, CNN, Foreign Ministry, Ministry of State Security, Mintz Group, American Chamber of Commerce, China’s Commerce Ministry, State Administration of Foreign Exchange Locations: China, Tokyo, Beijing, MOFA, Shanghai, Hong Kong

☆ China Arrests Japanese Executive Despite Tokyo’s Appeals
▼ + stars: | 2023-10-19 | by ( Miho Inada | ) www.wsj.com time to read: 1 min

The arrested Astellas Pharma executive disappeared in late March. Photo: Akio Kon/Bloomberg NewsTOKYO—China formally arrested a Japanese pharmaceutical executive who had been detained since March, Tokyo said Thursday, in a move likely to further chill business travel to the nation. Hirokazu Matsuno , Japan’s chief cabinet secretary, said the Astellas Pharma executive, whom China has previously identified as Hiroshi Nishiyama , was arrested in mid-October. Matsuno said Tokyo had made strong appeals to Beijing for the early release of the executive and would continue doing so.

Persons: Astellas, Akio Kon, Hirokazu, Hiroshi Nishiyama, Matsuno Organizations: Astellas Pharma, Bloomberg News TOKYO Locations: China, Tokyo, Beijing

☆ Foreign nationals detained in China
▼ + stars: | 2023-10-11 | by ( ) www.reuters.com time to read: +2 min

Here are some other high-profile cases of foreign nationals detained in China:YANG HENGJUNThe Australian writer has been detained in China for more than three years, and in 2021 was tried in Beijing on undisclosed national security charges. His arrest coincided with worsening relations between Australia and China and a verdict in his case has been repeatedly delayed. JAPANESE BUSINESSMANA Japanese employee of Astellas Pharma Inc, who has not been identified publicly, was detained in Beijing in March on suspicion of espionage, sending a chill through the Japanese business community in China. The Chinese foreign ministry, when asked last month if the Japanese employee had been arrested, said foreign nationals in China must abide by the country's laws or be prosecuted otherwise. KAI LILi, who is Chinese-American, has been detained in China since 2016.

Persons: Cheng Lei, YANG HENGJUN, Yang, ROBERT SCHELLENBERG, Meng Wanzhou, MARK SWIDAN, Katherine Swidan, KAI LI Li, Harrison Li, Laurie Chen, Don Durfee, Robert Birsel Organizations: Astellas Pharma Inc, Kyodo, Huawei, United, Reuters, Thomson Locations: BEIJING, Australian, China, Beijing, Australia, United States, Vancouver, Canada, MARK SWIDAN The Texas, United Nations

☆ Factbox-Foreign Nationals Detained in China
▼ + stars: | 2023-10-11 | by ( Oct. | At A.M. | ) www.usnews.com time to read: +2 min

Persons: Cheng Lei, YANG HENGJUN, Yang, ROBERT SCHELLENBERG, Meng Wanzhou, MARK SWIDAN, Katherine Swidan, KAI LI Li, Harrison Li, Laurie Chen, Don Durfee, Robert Birsel Organizations: Astellas Pharma Inc, Kyodo, Huawei, United, Reuters Locations: BEIJING, Australian, China, Beijing, Australia, United States, Vancouver, Canada, MARK SWIDAN The Texas, United Nations

☆ Japan says it continues to seek release of Astellas worker detained in China
▼ + stars: | 2023-09-21 | by ( ) www.reuters.com time to read: 1 min

TOKYO, Sept 21 (Reuters) - Japan is continuing its efforts to seek the prompt release of an employee ofAstellas Pharma (4503.T) who has been detained in China since March, Japan's top government spokesman said on Thursday. Chief Cabinet Secretary Hirokazu Matsuno was speaking at a press conference after Kyodo news agency reported on Wednesday that Beijing was expected to decide soon on whether to formally arrest the Japanese businessman, whom it detained on suspicion of espionage. Reporting by Kaori Kaneko Editing by Chang-Ran KimOur Standards: The Thomson Reuters Trust Principles.

Persons: Hirokazu Matsuno, Kaori Kaneko, Chang, Ran Kim Organizations: Astellas Pharma, Kyodo, Thomson Locations: TOKYO, Japan, China, Japan's, Beijing

☆ Biden administration unveils first 10 drugs subject to Medicare price negotiations
▼ + stars: | 2023-08-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +7 min

Fiasp and NovoLog, insulins made by Novo Nordisk The Medicare negotiations are the centerpiece of the Biden administration's efforts to rein in the rising cost of medications in the U.S. Drugmakers such as Merck and Johnson & Johnson and their supporters aim to derail the negotiations, filing at least eight lawsuits in recent months seeking to declare the policy unconstitutional. Drugmakers' legal challengesMerck, Johnson & Johnson, Bristol-Myers Squibb and Astellas Pharma are among the companies suing to halt the negotiation process. The suits make similar and overlapping claims that Medicare negotiations are unconstitutional. Biden and his top health officials have embraced the lawsuits as evidence that they're making progress in the fight to cut drug prices.

Persons: Biden, Joe Biden's, Boehringer Ingelheim, Johnson Januvia, Merck Farxiga, Novartis Enbrel, Amgen Imbruvica, AbbVie Stelara, Janssen, insulins, Johnson, Leigh Purvis, Drugmakers, drugmakers, Robert Davis Organizations: Bristol, Myers Squibb Jardiance, Johnson, Merck, AstraZeneca Entresto, Novartis, Novo Nordisk, Medicare, Centers, Services, Biden, AARP Public, Institute, Congressional, Office, Myers Squibb, Astellas Pharma, U.S . Chamber, Commerce, Supreme, Court, Circuit Court, Pharma, White, Big Pharma Locations: U.S, Bristol

☆ These 10 medications are likely targets for Medicare price negotiations this fall
▼ + stars: | 2023-08-10 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

Though it is still unclear which 10 drugs Medicare will select, several pharmaceutical companies have already revealed in court filings that they expect four of their blockbuster medications to be targeted. Bristol-Myers Squibb and Johnson & Johnson , in separate filings, said their blood thinners Eliquis and Xarelto will be subject to the negotiations this year. The list price of Januvia has surged 275% since 2006, according to the AARP. Johnson & Johnson reported $2.47 billion in revenue from Xarelto. "More and more people face cost-sharing that is directly affected by drug price increases," Leigh Purvis, who analyzes health-care costs for AARP, told reporters on a call Thursday.

Persons: Daniel Acker, Merck, Johnson, Abbvie, Imbruvica, Jardiance, Boehringer Ingelheim, Amgen Symbicort, Pfizer Xtandi, Breo, Biden, Januvia, Eliquis, Xarelto, Leigh Purvis Organizations: Merck, Co, Inc, Bloomberg, Getty, Medicare, Services, Myers Squibb, Johnson, Pharmacy, AstraZeneca Ibrance, Pfizer, Astellas Pharma, GSK, AARP, Bristol Myers Squibb, Jama Network, Industry Locations: Bristol, U.S, Januvia, Xarelto

☆ China spy agency’s social media debut calls for ‘all members of society’ to combat espionage
▼ + stars: | 2023-08-02 | by ( Chris Lau | ) edition.cnn.com time to read: +5 min

The Ministry of State Security oversees intelligence and counterintelligence both within China and overseas. Titled “Countering espionage requires the mobilization of all members of society,” the ministry said national security bodies should keep reporting channels, such as hotlines and online platforms, open to handle reports of suspected espionage within China in a timely manner. But those efforts have gathered pace under Xi Jinping, China’s most assertive and authoritarian leader in a generation who has made state security his top priority. Previous anti-spying driveThere have been multiple previous calls by China for the public to look for potential spies. In June last year, China announced “material rewards” of up to and above 100,000 yuan ($15,000) for tip-offs about people who endanger national security.

Persons: Hong Kong CNN —, ”, Xi Jinping, Greg Baker, Xiao Li, Li –, David Organizations: Hong Kong CNN, of State Security, CIA, FBI, Group, Bain & Company, Astellas Pharma, Getty Locations: Hong Kong, China, Beijing, American, Shanghai, Japan, AFP

China's Ministry of State Security on Tuesday said China should encourage its citizens to join counter-espionage work, including creating channels for individuals to report suspicious activity and rewarding them for doing do. A system that makes it "normal" for regular people to participate in counter-espionage should be established, the ministry said. That followed an expansion of China's counter-espionage law that took effect in July and bans the transfer of information it sees as related to national security. It has alarmed the United States, which has warned that foreign companies in China could be punished for regular business activities. China's declaration that it is under threat from spies comes as Western nations, most prominently the United States, accuse China of espionage and cyberattacks, a charge that Beijing has rejected.

Persons: Janet Yellen, Mark Schiefelbein, Matt Miller, Cheng Lei, Daphne Psaledakis, Humeyra Pamuk, Mark Porter, Rosalba O'Brien Organizations: China's Ministry of State Security, Astellas Pharma, Thomson Locations: United States, Diaoyutai, Beijing, China

☆ China wants to mobilise entire nation in counter-espionage
▼ + stars: | 2023-08-01 | by ( ) www.reuters.com time to read: +2 min

BEIJING, Aug 1 (Reuters) - China should encourage its citizens to join counter-espionage work, including creating channels for individuals to report suspicious activity as well as commending and rewarding them, the state security ministry said on Tuesday. Australian journalist Cheng Lei, accused by China for providing state secrets to another country, has been detained since September 2020. China's declaration that it is under threat from spies comes as Western nations, most prominently the United States, accuse China of espionage and cyberattacks, a charge that Beijing has rejected. The United States itself is the "empire of hacking," a Chinese foreign ministry spokesperson has said. In protecting itself from espionage, China would need the participation of its people in building a defence line, the state security ministry wrote in its WeChat post.

Persons: State Security Chen Yixin, Chen, Cheng Lei, Ryan Woo, Raju Gopalakrishnan Organizations: of State Security, State Security, Communist Party of China, Astellas Pharma, Thomson Locations: BEIJING, China, United States, Beijing

☆ Alibaba and more: Morgan Stanley names 5 global stocks with at least 50% upside
▼ + stars: | 2023-06-19 | by ( Ganesh Rao | ) www.cnbc.com time to read: +4 min

Morgan Stanley expects five of its top Asia stock picks to rise by more than 50% over the next 12 months. Alibaba Alibaba Group, the Chinese technology giant that's also listed in the United States, is making significant progress in its restructuring process, according to Morgan Stanley. "The likelihood of generics being immediately released in May 2024 is low," Morgan Stanley analysts Shinichiro Muraoka and Jaeheon Lee said in a note to clients on June 12. Sea Despite the challenges from inflation and post-pandemic economic reopenings, Morgan Stanley still sees long-term potential in Sea Limited . JD.com Morgan Stanley highlighted JD.com , a leading Chinese e-commerce company, for its potential growth as Chinese consumer spending picks up.

Persons: Morgan Stanley, Morgan Stanley's, Morgan, Gary Yu, Astellas, Astellas Pharma Morgan Stanley, Shinichiro Muraoka, Jaeheon Lee, JD.com Morgan Stanley, Eddy Wang, Ping, Jenny Jiang Organizations: Asia, Alibaba, Street, Astellas Pharma, Ping An Insurance Locations: Asia, Asia Pacific, Japan, China, India, United States, U.S, Singapore

☆ Xi Jinping says China's national security is faces a 'complex and grave' situation
▼ + stars: | 2023-05-31 | by ( Nectar Gan | ) edition.cnn.com time to read: +4 min

“The complexity and difficulty of the national security issues we now face have increased significantly,” Xi said Tuesday at a meeting of the party’s National Security Commission, state news agency Xinhua reported. Since coming to power a decade ago, Xi has made national security a key paradigm that permeates all aspects of China’s governance, experts say. He has expanded the concept of national security to cover everything from politics, economy, defense, culture and ecology to cyberspace. Under Xi’s notion of “comprehensive national security,” China has introduced a raft of legislation to protect itself against perceived threats, including laws on counter-terrorism, counter-espionage, cybersecurity, foreign non-government organizations, national intelligence and data security. In Hong Kong, a sweeping national security law was imposed by Beijing to stamp out dissent after huge democracy protests roiled the city.

Persons: Xi Jinping, ” Xi, “, Xi, Bill Bishop, Mintz, ” Organizations: Hong Kong CNN, party’s National Security Commission, Xinhua, Bain & Company, Mintz Group, Astellas Pharma Locations: Hong Kong, Communist, Beijing, China, People’s Republic of China, American

☆ Japan stocks are on fire this year. Here are 3 reasons why the rally could have 'staying power'
▼ + stars: | 2023-05-27 | by ( Sarah Min | ) www.cnbc.com time to read: +8 min

Since then, Japanese equities have rallied. Even so, Strategas Securities' Chris Verrone has remained optimistic on Japanese equities, saying this week that the rally is not yet overbought. Meanwhile, JPMorgan chief market strategist Marko Kolanovic said in a note, also on Tuesday, that the rally in Japan still has "staying power." For international investors, those remarks signaled that Japanese companies may be more transparent with shareholders in the future. Investors can also take a company-specific approach, according to Diamond Hill's Mohanraj, who favors Japanese companies that boast differentiated products.

☆ Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
▼ + stars: | 2023-05-17 | by ( David Carnevali | ) www.reuters.com time to read: +4 min

Even shares of drug companies that do not have pending deals but are seen by analysts and investors as potential acquisition targets were hit. FTC officials did not respond to a request for comment on whether they planned to challenge any other pharmaceutical acquisitions. "We could see similar challenges to the Pfizer/Seagen deal" BMO analysts wrote in a note, arguing that the FTC could target other major drug companies with the resources to engage in bundling. UNDER THE RADARConversely, investors and analysts are hoping that smaller pharmaceutical acquisitions will continue to fly under the radar of regulators. Reporting by David Carnevali in New York; Editing by Greg Roumeliotis and Jamie FreedOur Standards: The Thomson Reuters Trust Principles.

☆ China sentences 78-year-old US citizen to life in prison for espionage
▼ + stars: | 2023-05-15 | by ( Nectar Gan | ) edition.cnn.com time to read: +3 min

Hong Kong CNN —A 78-year-old American citizen has been sentenced to life in prison by a Chinese court on spying charges. Leung was detained on April 15, 2021 by state security authorities in Suzhou, Jiangsu province, according to the brief statement, which did not provide details on his charges. Chinese authorities and state media have not previously disclosed any information on Leung’s detention or the court process that led to his conviction. In China, cases involving state security are usually handled behind closed doors. In another high-profile case, two Canadians – former diplomat Michael Kovrig and businessman Michael Spavor – were detained by China for nearly three years.

Search resuls for: "Astellas"

25 mentions found